Skip to main content

Table 3 Multivariate Cox model for DDFS (n = 170) and OS (n = 174)

From: Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

Outcome

MV analysis of DDFS with nodal status

MV analysis of OS with nodal status

HR (95% CI)

p value

HR (95% CI)

p value

Age at initial diagnosis

1.01 (0.98, 1.04)

0.6608

1.03 ( 0.99, 1.07)

0.1252

Chemotherapy given in the first year following diagnosis

0.42 (0.11, 1.65)

0.2129

0.71 ( 0.16, 3.21)

0.6552

Metaplastic diagnosis

1.64 (0.75, 3.58)

0.2159

1.64 ( 0.69, 3.90)

0.2597

Positive nodes

4.32 (1.66, 11.29)

0.0028

2.62 ( 0.88, 7.82)

0.0844

Radiotherapy given

0.58 (0.23, 1.50)

0.2643

0.55 ( 0.20, 1.49)

0.2384

Stage 1

0.33 (0.06, 1.83)

0.0287

0.06 ( 0.01, 0.54)

0.0021

Stage 2

0.32 (0.14, 0.74)

—

0.07 ( 0.02, 0.28)

—

Stage 3

Ref

—

0.24 ( 0.06, 0.93)

—

Stage 4

—

—

Ref

—

  1. Abbreviations: CI = confidence interval; DDFS = distant disease-free survival; HR = hazard ratio; MV = multivariate; OS = overall survival